Fructolysis
From Wikipedia, the free encyclopedia
Fructolysis refers to the metabolism of fructose from dietary sources. Fructose, represents about 20% of dietary carbohydrate intake (60 – 80 g) in most individuals. The typical American diet contains approximately 50% of the carbohydrate as polysaccharides or starch and approximately 50% as mono and disaccharides (sugars, both naturally occurring and refined). Fructose is a dietary monosaccharide present naturally in fruits and vegetable either as free fructose or as part of the disaccharide sucrose, and as free monosaccharides (glucose and fructose) in honey. It is also present in our diets in the form of refined sugars including granulated sugars (white crystalline table sugar, brown sugar, confectioner’s sugar, turbinado sugar, and powdered sugar), refined crystalline fructose and as high fructose corn syrups. Certain foods such as apples, and pears contain considerable amounts of free fructose relative to glucose. They are problematic in this regard, since the free unopposed fructose (fructose in excess of glucose) is not well absorbed and has been shown to cause osmotic diarrhea. The major consumers of apple juice are infants and children, and there are several published reports in the pediatric literature raising concern about the osmotic diarrhea and potential for dehydration, especially in infants. Unlike glucose, fructose is not an insulin secretagogue. On the other hand, in contrast to glucose, fructose in not metabolized in insulin sensitive tissues (peripheral tissue). Fructose is selectively taken up and almost completely metabolized by hepatocytes in the liver (the only other cells capable of metabolizing fructose under normal conditions are spermatozoa. Very little fructose escapes the liver, and fructose is not metabolized to any great extent in the small intestine, which lacks the fructose phosphorylating enzyme fructokinase.
Contents
|
[edit] Fructolysis and Glycolysis are Independent Pathways
Although the metabolism of fructose and glucose share many of the same intermediate structures, they have very different metabolic fates in human metabolism. Fructose is metabolized almost completely in the liver in humans, and is directed toward replenishment of liver glycogen and triglyceride synthesis, while much of dietary glucose passes through the liver where it is metabolized in skeletal muscle to CO2, H2O and ATP, and to fat cells where it is metabolized primarily to glycerol phosphate for triglyceride synthesis as well as energy production. [1] The products of fructose metabolism are liver glycogen and de novo lipogenesis of fatty acids and eventual synthesis of endogenous triglyceride can be divided into two main phases: The first phase is the synthesis of the trioses, dihydroxyacetone(DHAP) and glyceraldehyde; the second phase is the subsequent metabolism of these trioses either in the gluconeogenic pathway for glycogen replenishment and/or the complete metabolism in the fructolytic pathway to pyruvate, which enters the Krebs cycle, is converted to citrate and subsequently directed toward ’’de novo’’ synthesis of the free fatty acid palmitate [2]
[edit] The Metabolism of Fructose to DHAP and Glyceraldehyde
The first step in the metabolism of fructose is the phosphorylation of fructose to fructose 1-phosphate by fructokinase ( Km = 0.5 mM, ≈ 9mg/100 ml), thus trapping fructose for metabolism in the liver. Hexokinase IV (Glucokinase), also occurs in the liver and would be capable of phosphorylating fructose to fructose-6-phosphate (an intermediate in the gluconeoenic pathway); however, it has a relatively high Km (12 mM) for fructose and, therefore, essentially all of the fructose is converted to fructose-1-phosphate in the human liver. Much of the glucose, on the other hand, is not phosphorylated (Km of hepatic glucokinase (hexokinase IV) = 10 mM), passes through the liver directed toward peripheral tissues, and is taken up by the insulin-dependent glucose transporter, GLUT 4, present on adipose tissue and skeletal muscle. Fructose-1-phosphate then undergoes hydrolysis by fructose-1-phosphate aldolase (aldolase B) to form dihydroxyacetone phosphate (DHAP) and glyceraldehyde; DHAP can either be isomerized to glyceraldehyde 3-phosphate by triosephosphate isomerase or undergo reduction to glycerol 3-phosphate by glycerol 3-phosphate dehydrogenase. The glyceraldehyde produced may also be converted to glyceraldehyde 3-phosphate by glyceraldehyde kinase or converted to glycerol 3-phosphate by glyceraldehyde 3-phosphate dehydrogenase. The metabolism of fructose at this point yields intermediates in gluconeogenic pathway leading to glycogen synthesis, or can be oxidized to pyruvate and reduced to lactate, or be decarboxylated to acetyl CoA in the mitochondria and directed toward the synthesis of free fatty acid, resulting finally in TG synthesis.
[edit] Figure 1 The Metabolic Conversion of Fructose to DHAP, Glyceraldehyde and Glyceraldehyde-3-Phosphate in the Liver
[edit] Synthesis of Glycogen from DHAP and Glyceraldehyde 3 Phosphate
The synthesis of glycogen in the liver following a fructose-containing meal proceeds from gluconeogenic precursors. Fructose is initially converted to DHAP and glyceraldehyde by fructokinase and aldolase B. The resultant glyceraldehyde then undergoes phosphorylation to glyceraldehyde-3-phosphate. Increased concentrations of DHAP and glyceraldehyde-3-phosphate in the liver drive the gluconeogenic pathway toward glucose-6-phosphate, glucose-1-phosphate and glycogen formation. It appears that fructose is a better substrate for glycogen synthesis than glucose and that glycogen replenishment takes precedence over triglyceride formation [3]. Once liver glycogen is replenished, the intermediates of fructose metabolism are primarily directed toward triglyceride synthesis.
[edit] Figure 2 The Metabolic Conversion of Fructose to Glycogen in the Liver
[edit] Synthesis of Triglyceride from DHAP and Glyceraldehyde-3-Phosphate
Carbons from dietary fructose are found in both the FFA and glycerol moieties of plasma TG. Excess dietary fructose can be converted to pyruvate, enter the Krebs cycle and emerges as citrate directed toward free fatty acid synthesis in the cytosol of hepatocytes. The DHAP formed during fructolysis can also be converted to glycerol and then glycerol 3-phosphate for TG synthesis. Thus, fructose can provide trioses for both the glycerol 3-phosphate backbone, as well as the free fatty acids in TG synthesis. Indeed, fructose may provide the bulk of the carbohydrate directed toward de novo TG synthesis in humans.
[edit] Figure 3 The Metabolic Conversion of Fructose to Triglyceride (TG) in the Liver
[edit] Fructose Induces Hepatic Lipogenic Enzymes
Fructose consumption results in the insulin-independent induction of several important hepatic lipogenic enzymes including pyruvate kinase, NADP+-dependent malate dehydrogenase, citrate lyase, acetyl CoA carboxylase, fatty acid synthase, as well as pyruvate dehydrogenase. Although not a consistent finding among metabolic feeding studies, high fructose diets have been shown to lead to hypertriglyceridemia in a wide range of populations including individuals with normal glucose metabolism as well as individuals with impaired glucose tolerance, diabetes, hypertriglyceridemia, and hypertension. The hypertriglyceridemic effects observed are a hallmark of increased dietary carbohydrate, and fructose and appears to be dependent on a number of factors including the amount of dietary fructose consumed and degree insulin resistance.
[edit] Table 1 Hepatic Lipogenic Enzyme Activity ‡ in Control and Streptozotocin Induced Diabetic Rats§ Follow a 14 day period with or without 25% Fructose Diet
| Group | Pyruvate Kinase | NADPH-Malate
Dehydrogenase |
Citrate Lyase | Acetyl CoA
Carboxylase |
Fatty Acid Synthase |
| Control Animals | |||||
| Control Diet | 495 ± 23 | 35 ± 5 | 21 ± 3 | 6.5 ± 1.0 | 3.6 ± 0.5 |
| Fructose Diet | 1380 ± 110* | 126 ± 9* | 69 ± 7* | 22.5 ± 2.7* | 10.8 ± 1.4* |
| Diabetic Animals | |||||
| Control Diet | 196 ± 21 | 14 ± 3 | 9 ± 2 | 3.1 ± 0.8 | 1.4 ± 0.6 |
| Fructose Diet | 648 ± 105* | 70 ± 9* | 37 ± 6* | 10.3 ± 2.0* | 3.9 ± 0.9* |
‡ = Mean ± SEM activity in nmol/min per mg protein
§ = 12 rats/group
∗ = Significantly different from control at p < 0.05
Shafrir, E. Fructose/Sucrose metabolism, its physiological and pathological implications. In Kretchmer, N. & Hollenbeck, CB. Sugars and Sweeteners, CRC Press, Boca Raton:FL, 1991
[edit] Abnormalities in Fructose Metabolism
The lack of two important enzymes in fructose metabolism results in the development of two inborn errors in carbohydrate metabolism – essential fructosuria and hereditary fructose intolerance. In addition, reduced phosphorylation potential within hepatocytes can occur with intravenous infusion of fructose.
[edit] Inborn Errors in Fructose Metabolism
[edit] Essential Fructosuria
The absence of fructokinase results in the inability to phosphorylate fructose to fructose-1-phosphate within the cell. As a result, fructose is neither trapped within the cell nor directed toward its metabolism. Free fructose concentrations in the liver increase and fructose is free to leave the cell and enter plasma. This results in an increase in plasma concentration of fructose, eventually exceeding the renal threshold for fructose reabsorption resulting in the appearance of fructose in the urine. Essential fructosuria is a benign asymptomatic condition.
[edit] Hereditary Fructose Intolerance
The absence of fructose-1-phosphate aldolase (aldolase B) results in the accumulation of fructose 1 phosphate in hepatocytes, kidney and small intestines. An accumulation of fructose-1-phosphateIt following fructose ingestion inhibits glycogenolysis (breakdown of glycogen) and gluconeogenesis, resulting in severe hypoglycemia. It is very symptomatic resulting in severe hypoglycemia, abdominal pain, vomiting, hemorrhage, jaundice, hepatomegaly, and hyperuricemia eventually leading to liver and/or renal failure and death. The incidence varies throughout the world, but is it estimated at about 1/20,000 (range 1/12,000 to 1/58,000) live births.
[edit] Reduced Phosphorylation Potential
Intravenous (i.v.) infusion of fructose has been shown to lower phosphorylation potential in liver cells by trapping Pi as fructose 1-phosphate. [4] The fructokinase reaction occurs quite rapidly in hepatocytes trapping fructose in cells by phosphorylation. On the other hand, the splitting of fructose 1 phosphate to DHAP and glyceraldehyde by Aldolase B is relatively slow. Therefore, fructose-1-phosphate accumulates with the corresponding reduction of intracellular Pi available for phosphorylation reactions in the cell. This is why fructose is contraindicated for total parenteral nutrition (TPN) solutions and is never given intravenously as a source of carbohydrate. It has been suggested that excessive dietary intake of fructose may also result in reduced phosphorylation potential. However, this is still a contentious issue. Dietary fructose is not well absorbed and increased dietary intake often results in malabsorption. Whether or not sufficient amounts of dietary fructose could be absorbed to cause a significant reduction in phosphorylating potential in liver cells remains questionable and there are no clear examples of this in the literature.
[edit] See also
[edit] References
- ^ McGrane, MM (2006). Carbohydrate Metabolism: Synthesis and Oxidation. Missouri: Saunders, Elsevier, 258-277.
- ^ McGrane, MM (2006). Carbohydrate Metabolism: Synthesis and Oxidation. Missouri: Saunders, Elsevier, 258-277.
- ^ Parniak, MA (1988). "Enhancement of glycogen concentrations in primary cultures of rat hepatocytes exposed to glucose and fructose". Biochemical Journal 251: 795-802.
- ^ Segebarth, C; Grivegnée AR, Longo R, Luyten PR, den Hollander JA. (1991). "In vivo monitoring of fructose metabolism in human liver by means of 32P magnetic resonance spectroscopy". Biochimie 73: 105-108.
|
||||||||||||||||||||||||||||||||||||||
